documents: FDA-2020-N-1307-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-1307-0001 FDA FDA-2020-N-1307 Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Notice 60 Day Proposed Information Collection 2020-07-07T04:00:00Z 2020 7 2020-07-07T04:00:00Z 2020-09-09T03:59:59Z 2020-09-09T01:02:15Z 2020-14514 0 0 090000648472b55c

Links from other tables